Answers are grounded in this paper and cite their sources.
release in primary human monocytes. 25 µg/ml SBDS inhibited the mRNA and protein expression of iNOS. Moreover, 50 µg/ml SBDS and 30 µg/ml doxycycline inhibited the release of VEGF in an inflammatory state in HMC 1.2 cells. Both drugs did not affect LL37 release. Doxycycline did not affect intracellular NO levels and iNOS expression. SBDS and doxycycline mediate anti-inflammatory and anti-angiogenic effects through similar but also different signaling molecules.
No takes yet. Share an insight, caveat, or question.
Rein et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: